Clinically Significant Inhibitors in Hemophilia A Patients from India Tend to Persist

Publisher： Karger

E-ISSN： 1421-9662|103|3|175-176

ISSN： 0001-5792

Source： Acta Haematologica, Vol.103, Iss.3, 2000-08, pp. : 175-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factor VIII Inhibitors in Patients with Hemophilia A

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Genetic Inversions among Hemophilia A Patients from Macedonia and Bulgaria

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-01 ,pp. : 192-194

Karger

Access to resources Recommend Favorite

Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors

By Knight Chris  

Advances in Therapy, Vol. 26, Iss. 1, 2009-01 ,pp. : 68-88

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors

By Joshi Ashish V.   Stephens Jennifer M.   Munro Vicki   Mathew Prasad   Botteman Marc F.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Factor VIII Inhibitors with Selective IgG Immunoadsorption – a Single Center Experience in 50 Patients with Acquired Hemophilia*

By  

Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 2, 2006-03 ,pp. : 160-164

Karger

Access to resources Recommend Favorite